Erin Colgan

Erin Colgan joined Flagship Pioneering in 2024 as Senior Vice President of Finance, working within the central finance operations team with a focus on financial planning, accounting operations, and procurement.

Erin brings over twenty years of finance and accounting experience to her role, with more than ten years making strategic financial and operational decisions for public and private, small- and large-cap life sciences firms. She joined Flagship from a publicly traded immune-oncology company, where she served as Chief Financial Officer (CFO), and she was previously with a private company helping to plan the launch of a Type II diabetes product.

Erin held numerous finance and accounting leadership roles at Vertex Pharmaceuticals, including Controller of international operations leading the creation of new entities in Europe, Australia, and South America. She also collaborated with senior leadership to oversee all G&A, commercial and inventory cost planning, along with global revenue planning and commercial forecasting. She began her career in audit at PwC in Boston.

Erin holds a B.A. in accounting from the University of Massachusetts, Amherst. She is currently a Board Member and Treasurer of MassBioEd.